Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

37.21
Delayed Data
As of Aug 23
 +0.09 / +0.24%
Today’s Change
35.04
Today|||52-Week Range
85.83
-25.31%
Year-to-Date

Today’s Trading

Previous close37.12
Today’s open36.94
Day’s range36.48 - 37.30
Volume1,336,198
Average volume (3 months)2,354,447
Market cap$3.6B
Dividend yield--
Data as of 08/23/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+1.01%
P/E ratio20.3
Price/Sales2.30
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.49-0.68%
OPKOPKO Health Inc-0.06-0.97%
ACADACADIA Pharmaceutica...+0.47+1.49%
PTLAPortola Pharmaceutic...+0.33+0.59%
Data as of 08/23/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts